SEARCH

SEARCH BY CITATION

Recent data indicate that chemotherapy treats cancer, at least in part, by facilitating an immune response to the tumor. The study results outlined in this issue highlight the potential benefits in devising an optimal strategy for integrating new immune-based therapies into the standard of care for various cancers.